Welcome to our dedicated page for TC BioPharm (Holdings) SEC filings (Ticker: TCBPY), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on TC BioPharm (Holdings)'s stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into TC BioPharm (Holdings)'s regulatory disclosures and financial reporting.
TC BioPharm (Holdings) plc reported that the directors of its subsidiary, TC BioPharm Limited, have appointed joint administrators from Alvarez and Marsal Europe LLP to manage the subsidiary's affairs. The appointed administrators are exploring options to sell the subsidiary's business and assets, explicitly including its intellectual property and R&D assets, with the stated objective of realizing value for creditors. The notice signals that the subsidiary is in formal administration and that future recoveries for creditors will depend on whether a sale or other restructuring can preserve asset value.
FAQ
What is the current stock price of TC BioPharm (Holdings) (TCBPY)?
What is the market cap of TC BioPharm (Holdings) (TCBPY)?
